semaglutide prescription for weight loss
5 Surprising Obstacles Block Your 2025 Prescription Weight Loss
Insurance claim rejections for GLP-1 receptor agonists rose 28% in Q4 2025, creating five major obstacles that now block many patients from obtaining a semaglutide prescription for weight loss. The FDA's 2025 review tightened eligibility, prompting insurers and clinicians to add new layers of documentation and specialist referrals.